Clinical trials
Phase 1/2 Stomach Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2008 | 2 |
| 2010 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Active, not recruiting | 6 |
| Recruiting | 4 |
| Terminated | 3 |
| Suspended | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 5 |
| Amgen | 3 |
| Hokkaido Gastrointestinal Cancer Study Group | 2 |
| Tokyo University | 2 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Eisai Co., Ltd. | 1 |
| Fukushima Medical University | 1 |
| Kyushu University | 1 |
| National Cancer Center Hospital East | 1 |
| National Cancer Center, Japan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomach Neoplasms | 23 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Biliary Tract Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Breast Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Endometrial Neoplasms | 2 |
| Esophageal Neoplasms | 2 |
| Melanoma | 2 |
| Ovarian Neoplasms | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.